IP Verse

Lederer & Keller patent opposition analysis

The comprehensive analysis of Lederer & Keller opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Lederer & Keller

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3574914	Corticosteroid Compositions	MERITAGE PHARMA	Sep 1, 2022	DR FALK PHARMA
EP3464373	Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal Cancer	BRISTOL MYERS SQUIBB	Jul 26, 2022	LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB
EP3437645	Film-Coated Tablet Having High Chemical Stability Of Active Ingredient	INTERCEPT PHARMACEUTICALS	Jun 21, 2022	SANDOZ
EP2585075	Methods Of Treatment For Esophageal Inflammation	MERITAGE PHARMA	May 4, 2022	DR FALK PHARMA
EP2863895	Tablet Formulation Comprising A Peptide And A Delivery Agent	NOVO NORDISK	Jan 11, 2022	TEVA PHARMACEUTICALS
EP3094681	Propylene-Based Impact Copolymers	EXXONMOBIL CHEMICAL PATENTS	Oct 19, 2021	LUMMUS NOVOLEN TECHNOLOGY
EP2545939	Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring	BIOMARIN PHARMACEUTICAL	Sep 14, 2021	TEVA PHARMACEUTICALS
EP3337467	Combination Therapy Using Liposomal Irinotecan And A Parp Inhibitor For Cancer Treatment	IPSEN BIOPHARM	Sep 9, 2021	SANDOZ
EP2478907	Methods And Compositions For Treating Cancer	COUGAR BIOTECHNOLOGY	Jul 6, 2021	TEVA PHARMACEUTICALS
EP3060582	Assays For Determining Plasma Kallikrein System Biomarkers	TAKEDA PHARMACEUTICAL	Jun 23, 2021	LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

Top companies who are the clients of Lederer & Keller

Company	Total
LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB	13
TEVA PHARMACEUTICALS	12
DR FALK PHARMA	8
DSM NUTRITIONAL PRODUCTS	5
HEXAL	5
SANDOZ	4
LUMMUS NOVOLEN TECHNOLOGY	3
TILLOTTS PHARMA	2
STADA ARZNEIMITTEL	2
HEXAL SANDOZ	2